You can buy or sell Merus and other stocks, options, ETFs, and crypto commission-free!
Merus N.V. Common Shares, also called Merus, is a clinical-stage immune-oncology company, which engages in the discovery and development of bi-specific antibody therapeutics. Read More Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg on June 16, 2003 and is headquartered in Utrecht, Netherlands.
52 Week High
52 Week Low
— per share
Expected May 28, After Hours